Inventurus Knowledge Solutions Limited (IKS) is a technology-enabled healthcare solutions provider that was incorporated in 2006 and offers a comprehensive care enablement platform to healthcare enterprises. The company primarily serves physician enterprises in the US, Canada, and Australia, with a strong focus on the US market. Inventurus Knowledge Solutions Limited provides technology-enabled healthcare solutions, focusing on outpatient and inpatient care through its comprehensive care enablement platform.
The company went public through an IPO that was opened for bidding from December 12, 2024 to December 16, 2024, with shares getting listed on BSE and NSE on December 19, 2024. The IPO price was set at ₹1,329 per share, and the IPO was valued at ₹2,497.92 crores.
IKS Health helps doctors and other healthcare providers by handling their paperwork and administrative tasks, offering services such as clinical support, medical documentation management, and virtual medical scribing. The company is a healthcare technology company that helps make it easier and faster for patients to get the care they need while reducing the administrative burden on healthcare providers.
The company partners with outpatient and inpatient healthcare organizations, enabling them to deliver superior clinical care through a fee-for-value model. IKS offers a comprehensive one-stop platform with diversified offerings across the outpatient and inpatient care value chain serving key stakeholders such as patients, physicians, nurses and healthcare organizations, leveraging digital evolution, transformation and automation technologies to create sustained value based on outcomes delivered.
For the full year ended March 2025, net profit rose 31.19% to Rs 486.06 crore compared to Rs 370.49 crore in the previous year, while sales rose 46.54% to Rs 2,663.99 crore compared to Rs 1,817.93 crore in the previous year. For Q4 FY25, net profit jumped 132.50% to Rs 147.80 crore compared to Rs 63.57 crore in the previous quarter, while sales rose 16.78% to Rs 723.96 crore compared to Rs 619.96 crore in the previous quarter.
- **Revenue**: ₹2,664 crores (FY25)
- **Net Profit**: ₹486 crores (FY25)
- **Market Cap**: ₹26,415.57 crores as of July 11, 2025
- **ROE**: 37.0% (3-year average)
- **ROCE**: 27.2%
The stock has a 52-week high of ₹2,189 and a 52-week low of ₹1,236.80, with a P/E ratio of 54.35. The stock is trading at 15.2 times its book value, and promoter holding stands at 63.7%.
In Q4 FY25, the company demonstrated robust financial performance, achieving a 17% year-on-year revenue growth and a significant 68% increase in EBITDA, despite a strategic reduction in its customer base to focus on higher-margin clients. This shift aligns with a broader transition towards a tech-led, patient-centric model in healthcare, capitalizing on a $1.5 trillion market opportunity driven by consolidation and evolving purchasing behaviors.
EBITDA margins have crossed 30% in Q3 FY25, representing a significant improvement from the 24% proforma margin of FY2024. The integration of advanced technologies, including Generative AI, is enhancing operational efficiency and scalability, while strategic partnerships are expanding market reach.
IKS Health introduced a fully AI-driven version of its Scribble product, enhancing clinical documentation through AI-generated clinical notes, natural language processing for precise capture of medical terminology, end-to-end automation from audio capture to documentation as well as HIPAA-compliant encryption ensuring data security. The product will enable improved patient access and satisfaction, reduced clinical burden as well as rapid turnaround time for clients.
As of March 31, 2024, the company has served nearly 853 US-based healthcare organizations. Some of their key clients include Mass General Brigham Inc., Texas Health Care PLLC, and The GI Alliance Management. Recent client acquisitions include Palomar Health & Palomar Health Medical Group (October 2024), Radiology Partners (October 2024), and Western Washington Medical Group (December 2024).
The company's main management includes Berjis M Desai as chairman and Sameer Chavan as the company secretary. The company is incorporated in the year 2006, with its registered office in Bldg #.5&6 Unit #.801 8th Floor, Mindspace SEZ Thane Belapur Road, Airoli, Maharashtra, 400708.
The company acquired Aquity Holdings, a company engaged in technology-enabled clinical documentation medical coding and revenue integrity solutions for healthcare, with effect from October 27, 2023 through its subsidiary IKS Inc. Recently, in June 2025, a subsidiary invested USD 17 million for 48.02% stake in healthcare support firm IKS WWMG MSO LLC.
Inventurus Knowledge Solutions Ltd stands as a significant player in the healthcare technology sector, with strong financial performance, growing market presence, and continued innovation in AI-driven healthcare solutions. The company's focus on the lucrative US healthcare market, combined with its technology-enabled platform approach, positions it well for continued growth in the expanding healthcare technology sector.
